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Abstract Synthetic peptides derived from the proregion of rat 
cathepsin B were used to identify functionally important regions 
and residues for cathepsin B inhibition. Successive 5 amino acid 
deletions of a 56 amino acid propeptide from both the N- and C- 
termini has allowed the identification of two regions important 
for inhibitory activity: the NTTWQ (residues 21p-25p) and 
CGTVL (42p--46p) regions. Alanine scanning of residues within 
these two regions indicates that Trp-24p and Cys-42p contribute 
strongly to inhibition, their replacement by Ala resulting in 
160- and 140-fold increases in Ki, respectively. 
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1. Introduction 
Cysteine proteases play an important role in several phys- 
iological processes uch as intracellular protein degradation 
[1], antigen processing [2] and bone resorption [3]. However, 
under conditions where they become deregulated, cysteine 
proteases are also implicated in a number of degradative 
and invasive pathological conditions, e.g., arthritis [4,5], tu- 
mor invasion and metastasis [6,7] and muscular dystrophy [8]. 
A number of potent inhibitors of cysteine proteases are avail- 
able. However, because of the diversity of cysteine proteases 
and their contribution to normal physiological processes, cys- 
teine protease inhibitors hould preferably be enzyme selec- 
tive in order to be considered for potential therapeutic appli- 
cations. Designing inhibitors that are highly selective has 
proven to be a difficult task for the cathepsin class of cysteine 
proteases due to their broad substrate specificity [9]. Some 
success has been obtained using E-64 analogs developed for 
the specific inhibition of cathepsin B [10]. In this case selec- 
tivity is achieved through interaction with the 'occluding loop' 
of cathepsin B, a structural feature particular to this enzyme 
[11,12]. Selective inhibition of cathepsin B has also been ob- 
served with a 56 amino acid peptide derived from the prore- 
gion of the enzyme [13]. This propeptide is a potent inhibitor 
of cathepsin B with a Ki of 0.4 nM, a value 14000-fold better 
than that for inhibition of papain [13]. This peptide is the 
most highly specific inhibitor of cathepsin B available so 
far. Similarly, a cathepsin L propeptide was also shown to 
be selective for its parent enzyme cathepsin L [14]. Clearly, 
in addition to being potent inhibitors, the propeptides of cys- 
teine proteases also contain features ensuring that inhibition is 
highly selective for the proteases from which they originate. 
In this paper we report a detailed systematic study aimed at 
defining functionally important regions or residues for the 
inhibition of cathepsin B by its propeptide. To achieve this, 
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we have used N- and C-terminal truncated synthetic peptides, 
coupled to alanine-scanning on identified important regions. 
2. Materials and methods 
2.1. Materials 
The peptides were prepared by standard Fmoc chemistry on an 
Applied Biosystems 431A solid-phase ynthesizer. The crude peptides 
were purified to homogeneity b HPLC on a Vydak C18 preparative 
column (22 x 250 mm) using a linear 0-70% CH3CN gradient (con- 
taining 0.1% TFA). Identity of the peptides was confirmed using elec- 
trospray mass pectrometric analysis on a SCIEX API III spectrom- 
eter and amino acid analysis on a Beckman model 6300 amino-acid 
analyzer. Peptide purity was assessed by HPLC on a Vydak C18 
(4.6 × 250 mm) column using the same gradient as for the purification 
procedure. 
The substrate CBZ-Phe-Arg-MCA (carbobenzoxy-L-phenylalanyl-L- 
arginine 4-methylcoumarinyl-7-amide hy rochloride) was purchased 
from IAF Biochem International Inc., Laval, Canada. Recombinant 
cathepsin B expressed in yeast [15] was purified from the culture 
supernatant asdescribed previously [13]. The enzyme was stored in 
the PDS-inactived form (1.5 mM 2-PDS, 50 mM sodium formate, pH 
4.0) and activated by diluting stock enzyme into phosphate buffer (pH 
6.0) containing 1mM DTT for 15 min on ice. 
2.2. Methods 
Cathepsin B activity was measured using the substrate CBZ-Phe- 
Arg-MCA as described previously [16]. All measurements were per- 
formed at 25°C in 0.1 M phosphate buffer (pH 6.0) containing 1mM 
EDTA, 1 mM DTT, 0.025% Brij-35 and 3% DMSO. The dissociation 
constants Ki were determined from 1/v vs. [I] plots [17] obtained by 
measuring the initial rate of substrate hydrolysis (v) in the presence of
varying concentrations of inhibitor and at a substrate concentration 
of 20 ~tM, well below the KM value. For some inhibitors non-linearity 
in the initial portion of the progress curves indicated the presence ofa 
'slow inhibition' process and the data was analyzed as described pre- 
viously [13]. 
3. Results and discussion 
The sequence of the propeptide previously found to be a 
potent inhibitor of rat cathepsin B is reported in Fig. 1. The 
peptide corresponds to residues lp to 56p of the rat cathepsin 
B proregion. Two series of peptides corresponding to succes- 
sive deletions every five residues from both N- and C-termini 
of this 56 amino acid peptide were synthesized and their in- 
hibitory activity against cathepsin B assayed. The results are 
reported in Fig. 2a. It can be seen that successive deletions of 
5 residues from both ends of the propeptide result in a pro- 
gressive increase in Ki for up to 20 and 10 residue deletions in 
the N- and C-terminal regions, respectively. For these six 
peptides the Ki value does not go higher than 150 nM and 
they can still be considered good inhibitors of cathepsin B. 
Further deletions on either end cause a relatively important 
decrease of inhibitory activity. This is best visualized in Fig. 
2b, where AKi represents he ratio of Ki values for each suc- 
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Fig. 1. Sequence of a 56 amino acid peptide corresponding to residues lp to 56p of the rat cathepsin B proregion [20]. Propeptide numbering 
is based on the procathepsin B sequence starting at the N-terminal amino acid. Residues in the propeptide are identified with the suffix p. Two 
regions identified as being functionally important are marked by gray-shaded boxes. 
cessive 5 amino acid deletion. Removal of the N-terminal 
fragment 21p-25p (NTTWQ) causes a 150-fold increase in 
K~ while removal of the C-terminal 42p-46p residues 
(CGTVL) leads to an even greater increase in Ki 
(AKi=625). The resulting peptides, prcb(26p-56p) and 
prcb(1p41p), display Ki values of 9.7 gM and 83 gM, respec- 
tively. Further truncations result in gradual but less important 
increases in Ki up to mM values. 
The systematic removal of 5 amino acid fragments from 
both ends of the propeptide has allowed us to identify two 
seemingly important functional regions of the cathepsin B 
propeptide: the NTTWQ and CGTVL regions (Fig. 1). To 
evaluate the contribution of individual amino acid side chains 
within these regions, 10 synthetic peptides were prepared 
where residues 21p-25p and 42p-46p were individually re- 
placed by an alanine. The peptide template used for this study 
is prcb(21p-56p) which is shorter than the 56 amino acid 
peptide by 20 residues yet it still displays good inhibitory 
activity (Ki = 65 nM). The results are illustrated in Fig. 3. 
For the NTTWQ region (Fig. 3a) it can be seen that the 
tryptophan residue at position 24p contributes the most to 
inhibitory activity, replacement of Trp-24p by Ala causing a 
160-fold increase in Ki. Cys-42p in the CGTVL region is also 
an important residue, its replacement by Ala causing a 140- 
fold increase in Ki. Amongst the remaining residues in these 
two regions, replacement of Gly-43p and Leu-46p has a mod- 
erate 14-fold effect on inhibition while other replacements 
have less significant effects. 
The results obtained with the truncated propeptides indicate 
that part of the N- and C-terminal regions are not essential 
for inhibition and it delimits the most important region of the 
propeptide to residues 21p to 46p. A similar but less system- 
atic study of the interaction between cathepsin L and its pro- 
peptide also indicated that 20 and 15 amino acids could be 
removed from the N- and C-terminal parts of the propeptide 
without destroying the inhibitory activity [14]. Recently, the 
structure of human procathepsin B has been solved [18,19]. 
Assuming the propeptide interacts with cathepsin B in the 
same manner as the proregion in procathepsin B, the avail- 
ability of the data presented in this work allows the functional 
evaluation of structural features evidenced by the proenzyme 
structure. The first 10 amino acids at the N-terminus of pro- 
cathepsin B were found to be disordered and mobile in the 
crystal and other than the covalent link to the N-terminus of 
the mature enzyme the C-terminal region beyond residue 48p 
makes little contact with the enzyme. Accordingly, deletion of 
these residues does not greatly affect the inhibitory activity of 
the propeptide. As shown by the X-ray structure residues 
1 lp-20p form a three-turn (x-helix and N-terminal deletions 
up to residue 16p cause a progressive increase in Ki, indicating 
that this region contributes to the inhibitory activity. It is 
perhaps somewhat surprising, however, to find that peptide 
prcb(21p-56p), where the residues forming the a-helix are 
absent, is still a good inhibitor of cathepsin B with a Ki of 
65 nM. It can be seen in Fig. 2a that the 5 amino acid deletion 
from residue 16p to 21p actually causes a small 2.4-fold de- 
crease in Ki. It was found that N-terminal acetylation of 
prcb(21p-56p) resulted in a 30-fold increase in Ki, to a value 
of 2.0 gM, and it is possible that the free N-terminus present 
in prcb(21p-56p) could interact with the enzyme and in part 
compensate for the loss of the c~-helix. 
The alanine scanning experiments can be used to evaluate 
the functional contribution of individual side chains to inhibi- 
tion. The aromatic side chain of Trp-24p in NTTWQ is posi- 
tioned in a depression on the surface of cathepsin B occupied 
by two aromatic side chains (Tyr-183 and Tyr-188). Replace- 
ment of Trp-24p by an alanine confirms that this interaction, 
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Fig. 2. Influence of N- and C-terminal truncations on the inhibi- 
tory activity of the cathepsin B propeptide. (a) Ki as a function of 
the N- or C-terminal residue. The effect of N-terminal deletions is 
represented by the black squares for peptides with an intact C-term- 
inal residue (56p) and varying N-terminal residues indicated on the 
x-axis. Similarly, C-terminal deletions are represented by white 
squares for peptides starting with residue lp and ending at the posi- 
tion indicated on the x-axis. (b) Relative ffect of succesive 5 amino 
acid deletions. AKi represents he ratio of Ki values for two succes- 
sive peptides differing by a 5 residue deletion (e.g., Ki for prcb(1 lp- 
56p)/Ki for prcb(6p~56p)). 
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Fig. 3. Alanine scan of the NTTWQ (a) and CGTVL (b) regions. 
The results are reported as the ratio of Ki for the Ala derivative 
over Ki for peptide prcb(211~56p). 
even though it is located far from the active site, contributes 
significantly to inhibition. The CGTVL region also found to 
be important for inhibition is located at the active site of 
cathepsin B. This peptide stretch adopts an extended confor- 
mation but binds to the active site in a direction opposite to 
that expected for a substrate, therefore preventing hydrolysis. 
The side chain of residue Cys-42p occupies the $1' subsite and 
interacts with many hydrophobic residues. Gly-43p penetrates 
deep into the active site and is in close contact to Gly-27. 
Replacement of Gly-23p by an alanine cause a 14-fold in- 
crease in Ki, and it is expected from the structure that sub- 
stitution by residues with larger side chains would not be 
tolerated in this position. Further work will involve functional 
characterization of residues in the central region of the pro- 
peptide which, based on the procathepsin B structure, are 
suspected to be functionally important for inhibition of 
cathepsin B. 
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